Salud financiera de hoja de balance de ProPhase Labs
Salud financiera controles de criterios 3/6
ProPhase Labs tiene un patrimonio de los accionistas total de $49.4M y una deuda total de $10.3M, lo que sitúa su ratio deuda-patrimonio en 20.8%. Sus activos y pasivos totales son $91.9M y $42.5M respectivamente.
Información clave
28.3%
Ratio deuda-patrimonio
US$12.68m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$1.23m |
| Patrimonio | US$44.87m |
| Total pasivo | US$45.17m |
| Activos totales | US$90.03m |
Actualizaciones recientes sobre salud financiera
Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt
Aug 11
ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly
Jan 24We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt
Jul 26ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely
Mar 23Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt
Nov 30Recent updates
Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?
Mar 04ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry
Jan 09ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate
Sep 21Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt
Aug 11We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease
Apr 07ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly
Jan 24ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential
Oct 13ProPhase Labs Q2 2022 Earnings Preview
Aug 10We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt
Jul 26ProPhase Labs to license two investigational cancer compounds from Global BioLife
Jul 21ProPhase Labs: A Stellar Quarter And Another Special Dividend
May 16ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 08ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely
Mar 23Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt
Nov 30As Employer Vaccine Mandates Fail, Prophase Labs Could Benefit
Oct 20Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)
Jul 22ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants
Jun 28Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More
May 14ProPhase Labs partners with Dutchess County New York to provide COVID-19 testing
May 06A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)
Apr 12ProPhase Labs opens Covid testing facility in New York
Jan 29ProPhase Labs announces $5.5M registered direct offering of common stock and warrants
Jan 05Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($47.6M) de PRPH superan a sus pasivos a corto plazo ($20.9M).
Pasivo a largo plazo: Los activos a corto plazo de PRPH ($47.6M) superan a sus pasivos a largo plazo ($21.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (11.2%) de PRPH se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de PRPH ha crecido de 0% a 20.8% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Datos insuficientes para determinar si PRPH tiene suficiente cash runway basado en su flujo de caja libre actual.
Pronóstico de cash runway: Datos insuficientes para determinar si PRPH tiene suficiente cash runway en caso de que su flujo de caja libre siga creciendo o disminuyendo basado en tasas históricas.